Document Detail


Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.
MedLine Citation:
PMID:  16740699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Early developmental perturbations have been linked to adult-onset prostate pathology, including excessive exposure to estrogenic compounds; however, the molecular basis for this imprinting event is not known. An important and controversial health concern is whether low-dose exposures to hormonally active environmental estrogens, such as bisphenol A, can promote human diseases, including prostate cancer. Here, we show that transient developmental exposure of rats to low, environmentally relevant doses of bisphenol A or estradiol increases prostate gland susceptibility to adult-onset precancerous lesions and hormonal carcinogenesis. We found permanent alterations in the DNA methylation patterns of multiple cell signaling genes, suggesting an epigenetic basis for estrogen imprinting. For phosphodiesterase type 4 variant 4 (PDE4D4), an enzyme responsible for cyclic AMP breakdown, a specific methylation cluster was identified in the 5'-flanking CpG island that was gradually hypermethylated with aging in normal prostates, resulting in loss of gene expression. Early and prolonged hypomethylation at this site following neonatal estradiol or bisphenol A exposure resulted in continued, elevated PDE4D4 expression. Cell line studies confirmed that site-specific methylation is involved in transcriptional silencing of the PDE4D4 gene and showed hypomethylation of this gene in prostate cancer cells. Importantly, the PDE4D4 alterations in the estrogen-exposed prostates were distinguishable before histopathologic changes of the gland, making PDE4D4 a candidate molecular marker for prostate cancer risk assessment as a result of endocrine disruptors. In total, these findings indicate that low-dose exposures to ubiquitous environmental estrogens affect the prostate epigenome during development and, in so doing, promote prostate disease with aging.
Authors:
Shuk-Mei Ho; Wan-Yee Tang; Jessica Belmonte de Frausto; Gail S Prins
Related Documents :
17308099 - Ngep, a prostate-specific plasma membrane protein that promotes the association of lnca...
17875519 - Alpha-methylacyl coenzyme a racemase, ki-67, and topoisomerase iialpha in cystoprostate...
17690889 - Biomarkers for prostate cancer.
24188259 - Management of patients with biochemical recurrence after local therapy for prostate can...
23691439 - Research development of the relationship between thymidine phosphorylase expression and...
12955079 - Expression of the zinc transporter znt4 is decreased in the progression from early pros...
10336999 - Microsatellite instability and k-ras mutations in gastric adenomas, with reference to a...
6178589 - Salivary-type hyperamylasemia in primary lung cancer: observation of a possible precurs...
1364209 - Clinical manifestations of bronchogenic carcinoma.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Cancer research     Volume:  66     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-02     Completed Date:  2006-07-27     Revised Date:  2014-09-21    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5624-32     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3',5'-Cyclic-AMP Phosphodiesterases / genetics*
Animals
Animals, Newborn
Benzhydryl Compounds
Cyclic Nucleotide Phosphodiesterases, Type 4
DNA Methylation / drug effects*
Dose-Response Relationship, Drug
Epigenesis, Genetic
Estradiol / toxicity*
Female
Genetic Predisposition to Disease
Genomic Imprinting / drug effects
Isoenzymes / genetics
Male
Phenols / toxicity*
Precancerous Conditions / chemically induced,  enzymology,  genetics
Pregnancy
Prostate / drug effects
Prostatic Neoplasms / chemically induced*,  enzymology,  genetics*
Rats
Rats, Sprague-Dawley
Grant Support
ID/Acronym/Agency:
DK40890/DK/NIDDK NIH HHS; ES12281/ES/NIEHS NIH HHS; R01 ES015584/ES/NIEHS NIH HHS; R21 ES012281/ES/NIEHS NIH HHS; R21 ES012281-03/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Benzhydryl Compounds; 0/Isoenzymes; 0/Phenols; 4TI98Z838E/Estradiol; EC 3.1.4.17/3',5'-Cyclic-AMP Phosphodiesterases; EC 3.1.4.17/Cyclic Nucleotide Phosphodiesterases, Type 4; MLT3645I99/bisphenol A
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.
Next Document:  Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial...